KLok的个人主页 - 老虎社区

KLok

KLok

暂无个人介绍

IP属地：未知

0关注

49粉丝

0主题

0勋章

2021-12-23

Well done

@秋虫语冰:$TSLA 20211223 1000.0 CALL$ 盘前表现不错，马总给力！

2021-12-18

$Tesla Motors(TSLA)$[Call] [Call] [Call]

2021-11-24

Good news....

抱歉，原内容已删除

2021-11-23

Good news...

抱歉，原内容已删除

2021-11-19

Bad news for Tesla.

抱歉，原内容已删除

2021-11-14

Good news.....

Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>

2021-11-12

$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]

2021-11-11

$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]

2021-11-10

Bad news for the market.

抱歉，原内容已删除

2021-11-10

$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]

2021-11-09

$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]

2021-11-09

$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]

2021-11-09

$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]

2021-11-06

$Pfizer(PFE)$[捂脸] I sold yesterday at $46.50....

2021-11-05

Good news.

US mandates vaccines or tests for big companies by Jan. 4<blockquote>美国要求大公司在1月4日之前接种疫苗或进行测试</blockquote>

2021-11-05

$Pfizer(PFE)$[看跌] [看跌] [看跌]

2021-11-03

$Pfizer(PFE)$sold at$ $45.65

2021-11-02

$Tesla Motors(TSLA)$[捂脸]

2021-11-02

$Pfizer(PFE)$[看涨] [看涨] [看涨]

2021-11-01

$Pfizer(PFE)$[看涨] [看涨] [看涨]

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582450584533032","uuid":"3582450584533032","gmtCreate":1619400809948,"gmtModify":1620044598018,"name":"KLok","pinyin":"klok","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":49,"headSize":0,"tweetSize":327,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.12.11","exceedPercentage":"93.90%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.20%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":698002689,"gmtCreate":1640254446848,"gmtModify":1640254447499,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"Well done","listText":"Well done","text":"Well done","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698002689","repostId":"691779338","repostType":1,"repost":{"id":691779338,"gmtCreate":1640251927419,"gmtModify":1640251927419,"author":{"id":"3463112040984428","authorId":"3463112040984428","name":"秋虫语冰","avatar":"https://static.tigerbbs.com/97260ad2eb80155b4228f8f6ea0f6877","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3463112040984428","idStr":"3463112040984428"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/OPT/TSLA 20211223 1000.0 CALL\">$TSLA 20211223 1000.0 CALL$&nbsp;</a>盘前表现不错，马总给力！","listText":"<a href=\"https://laohu8.com/OPT/TSLA 20211223 1000.0 CALL\">$TSLA 20211223 1000.0 CALL$&nbsp;</a>盘前表现不错，马总给力！","text":"$TSLA 20211223 1000.0 CALL$ 盘前表现不错，马总给力！","images":[{"img":"https://static.tigerbbs.com/b1d5db726f58b7069f8819b50223e000","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691779338","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2881,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699844653,"gmtCreate":1639786116595,"gmtModify":1639786117166,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[Call]&nbsp;[Call]&nbsp;[Call]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[Call]&nbsp;[Call]&nbsp;[Call]&nbsp;","text":"$Tesla Motors(TSLA)$[Call] [Call] [Call]","images":[{"img":"https://static.tigerbbs.com/372e25bfd36cdb3dfda4fbe5859388e9","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699844653","isVote":1,"tweetType":1,"viewCount":2168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":875755194,"gmtCreate":1637705600615,"gmtModify":1637705600846,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"Good news....","listText":"Good news....","text":"Good news....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875755194","repostId":"2185338899","repostType":2,"isVote":1,"tweetType":1,"viewCount":2753,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875353784,"gmtCreate":1637617783402,"gmtModify":1637617828868,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"Good news...","listText":"Good news...","text":"Good news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875353784","repostId":"2185877459","repostType":2,"isVote":1,"tweetType":1,"viewCount":3140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876368641,"gmtCreate":1637273621521,"gmtModify":1637273621789,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"Bad news for Tesla.&nbsp;","listText":"Bad news for Tesla.&nbsp;","text":"Bad news for Tesla.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876368641","repostId":"2184994048","repostType":2,"isVote":1,"tweetType":1,"viewCount":2466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873980988,"gmtCreate":1636841899814,"gmtModify":1636841900156,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"Good news.....","listText":"Good news.....","text":"Good news.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873980988","repostId":"1102251183","repostType":2,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其努力分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其努力分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879068524,"gmtCreate":1636671668556,"gmtModify":1636671669385,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/32ceca53d53cc41a27dd706cc2c8723e","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879068524","isVote":1,"tweetType":1,"viewCount":1942,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":870951479,"gmtCreate":1636583599657,"gmtModify":1636583648474,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/abd8786d602813e2c19b9c1c1c32d38b","width":"1080","height":"2259"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870951479","isVote":1,"tweetType":1,"viewCount":2362,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":847348082,"gmtCreate":1636497875885,"gmtModify":1636497876562,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"Bad news for the market.&nbsp;","listText":"Bad news for the market.&nbsp;","text":"Bad news for the market.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/847348082","repostId":"1127189501","repostType":2,"isVote":1,"tweetType":1,"viewCount":2411,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847366823,"gmtCreate":1636495044938,"gmtModify":1636495045706,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/f2f53cce83b695dbeff08f53037b0bcd","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847366823","isVote":1,"tweetType":1,"viewCount":3274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":847004734,"gmtCreate":1636466289550,"gmtModify":1636466418494,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/667477543e637a82db9490698f127c31","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847004734","isVote":1,"tweetType":1,"viewCount":971,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844117193,"gmtCreate":1636410815826,"gmtModify":1636410816521,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/ed9dcbf9d7b5120fd12dca9f3bc99792","width":"1080","height":"2259"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844117193","isVote":1,"tweetType":1,"viewCount":733,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844322150,"gmtCreate":1636391797786,"gmtModify":1636391798498,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/d1afe6769139e0cb6b2979b77f9fb458","width":"1080","height":"2172"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844322150","isVote":1,"tweetType":1,"viewCount":952,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":842101744,"gmtCreate":1636152342303,"gmtModify":1636152343127,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[捂脸]&nbsp;I sold yesterday at $46.50....","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[捂脸]&nbsp;I sold yesterday at $46.50....","text":"$Pfizer(PFE)$[捂脸] I sold yesterday at $46.50....","images":[{"img":"https://static.tigerbbs.com/591cb543ecb19b575998bfdc2edf29ee","width":"1080","height":"2259"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842101744","isVote":1,"tweetType":1,"viewCount":916,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":846198298,"gmtCreate":1636066216008,"gmtModify":1636066216786,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"Good news.","listText":"Good news.","text":"Good news.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846198298","repostId":"1198892706","repostType":4,"repost":{"id":"1198892706","kind":"news","pubTimestamp":1636039736,"share":"https://www.laohu8.com/m/news/1198892706?lang=zh_CN&edition=full","pubTime":"2021-11-04 23:28","market":"us","language":"en","title":"US mandates vaccines or tests for big companies by Jan. 4<blockquote>美国要求大公司在1月4日之前接种疫苗或进行测试</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1198892706","media":"Associated Press News","summary":"Tens of millions of Americans who work at companies with 100 or more employees will need to be fully","content":"<p>Tens of millions of Americans who work at companies with 100 or more employees will need to be fully vaccinated against COVID-19 by Jan. 4 or get tested for the virus weekly under government rules issued Thursday.</p><p><blockquote>根据周四发布的政府规定，在拥有100名或更多员工的公司工作的数千万美国人需要在1月4日之前全面接种COVID-19疫苗，或者每周接受病毒检测。</blockquote></p><p> The new requirements, which were first previewed by President Joe Biden in September, will apply to about 84 million workers at medium and large businesses, although it is not clear how many of those employees are unvaccinated.</p><p><blockquote>美国总统乔·拜登(Joe Biden)于9月份首次预览了这些新要求，将适用于大中型企业的约8400万名员工，尽管尚不清楚其中有多少员工未接种疫苗。</blockquote></p><p> The Occupational Safety and Health Administration regulations will force the companies to require that unvaccinated workers test negative for COVID-19 at least once a week and wear a mask while in the workplace.</p><p><blockquote>职业安全与健康管理局的规定将迫使公司要求未接种疫苗的工人每周至少进行一次新冠肺炎病毒检测呈阴性，并在工作场所佩戴口罩。</blockquote></p><p> OSHA left open the possibility of expanding the requirement to smaller businesses. It asked for public comment on whether employers with fewer than 100 employees could handle vaccination or testing programs.</p><p><blockquote>OSHA保留了将该要求扩展到小型企业的可能性。它就员工少于100人的雇主是否可以处理疫苗接种或检测项目征求公众意见。</blockquote></p><p> Tougher rules will apply to another 17 million people who work in nursing homes, hospitals and other facilities that receive money from Medicare and Medicaid. Those workers will not have an option for testing — they will need to be vaccinated.</p><p><blockquote>更严格的规定将适用于另外1700万在疗养院、医院和其他接受医疗保险和医疗补助的机构工作的人。这些工人将没有检测的选择——他们需要接种疫苗。</blockquote></p><p> Workers will be able to ask for exemptions on medical or religious grounds.</p><p><blockquote>工人将能够以医疗或宗教为由要求豁免。</blockquote></p><p> OSHA said companies that fail to comply with the regulations could face penalties of nearly $14,000 per violation.</p><p><blockquote>OSHA表示，不遵守规定的公司每次违规可能面临近14,000美元的罚款。</blockquote></p><p> It was unclear how OSHA planned to enforce the rules: Even counting allied regulators at the state level, the agency&nbsp;has only 1,850 inspectors&nbsp;to oversee 130 million workers at 8 million workplaces. A senior administration official said OSHA will target companies if it gets complaints.</p><p><blockquote>目前尚不清楚OSHA计划如何执行这些规则：即使算上州一级的联合监管机构，该机构也只有1,850名检查员来监管800万个工作场所的1.3亿名工人。一名高级政府官员表示，如果收到投诉，OSHA将针对公司。</blockquote></p><p> The release of the rules followed weeks of regulatory review and meetings with business groups, labor unions and others. The regulations form the cornerstone of Biden’s most aggressive effort yet to combat the spread of COVID-19, which has killed more than 740,000 people in the U.S.</p><p><blockquote>这些规则是在经过数周的监管审查以及与商业团体、工会和其他人的会议之后发布的。这些规定是拜登迄今为止最积极努力抗击COVID-19传播的基石，该病毒已在美国造成超过74万人死亡。</blockquote></p><p> OSHA drafted the rules under emergency authority meant to protect workers from an imminent health hazard. The agency estimated that the vaccine mandate will save more than 6,500 worker lives and prevent more than 250,000 hospitalizations over the next six months.</p><p><blockquote>OSHA根据紧急授权起草了这些规则，旨在保护工人免受迫在眉睫的健康危害。该机构估计，疫苗授权将在未来六个月内挽救6,500多名工人的生命，并防止超过250,000人住院。</blockquote></p><p> Senior administration officials said the rules preempt conflicting state laws or orders, including those that ban employers from requiring vaccinations, testing or the wearing of face masks.</p><p><blockquote>高级政府官员表示，这些规定优先于相互冲突的州法律或命令，包括那些禁止雇主要求接种疫苗、检测或戴口罩的法律或命令。</blockquote></p><p> The administration will face an immediate challenge from Republican state officials who are eager to fight Biden in court and in Congress. Senate Republicans immediately launched a petition to force a vote to overturn the vaccine mandate, but with Democrats controlling the chamber, the effort is nearly certain to fail.</p><p><blockquote>政府将立即面临共和党州官员的挑战，他们渴望在法庭和国会与拜登对抗。参议院共和党人立即发起请愿，要求投票推翻疫苗授权，但由于民主党控制了众议院，这一努力几乎肯定会失败。</blockquote></p><p> More than two dozen Republicans serving as state attorneys general have indicated they plan to sue, arguing that only Congress can enact such sweeping requirements under emergency authority.</p><p><blockquote>二十多名担任州总检察长的共和党人表示，他们计划提起诉讼，认为只有国会才能根据紧急权力制定如此全面的要求。</blockquote></p><p> Last week, 19 states sued to stop Biden’s narrower mandate that employees of federal contractors be vaccinated. That requirement was scheduled to take effect Dec. 8, but the administration said Thursday it will be delayed until Jan. 4 to match the requirements on other large employers and health care providers.</p><p><blockquote>上周，19个州提起诉讼，要求阻止拜登对联邦承包商员工接种疫苗的狭隘要求。该要求原定于12月8日生效，但政府周四表示，将推迟到1月4日，以符合其他大型雇主和医疗保健提供商的要求。</blockquote></p><p> The&nbsp;rules&nbsp;will require workers to receive either two doses of the Pfizer or Moderna vaccines or one dose of the Johnson &amp; Johnson vaccine by Jan. 4 or be tested weekly. Employees who test positive must be removed from the workplace.</p><p><blockquote>这些规定将要求工人在1月4日之前接受两剂辉瑞或Moderna疫苗或一剂强生疫苗，或者每周接受一次检测。检测呈阳性的员工必须被带离工作场所。</blockquote></p><p> The requirements will not apply to people who work at home or outdoors.</p><p><blockquote>这些要求不适用于在家或户外工作的人。</blockquote></p><p> Companies won’t be required to provide or pay for the tests, but they must give paid time off for employees to get vaccines and sick leave to recover from side effects that prevent them from working. The requirements for masks and paid time off for shots will take effect Dec. 5.</p><p><blockquote>公司不会被要求提供或支付测试费用，但他们必须给员工带薪休假来接种疫苗和病假，以从阻止他们工作的副作用中恢复过来。戴口罩和带薪休假的要求将于12月5日生效。</blockquote></p><p> The Centers for Medicare &amp; Medicaid Services issued a separate rule requiring vaccination for workers in 76,000 health facilities and home health care providers that get funding from the government health programs. A senior administration official said that several large private health care organizations imposed their own mandates and achieved high vaccination rates — 96% or higher — without widespread resignations.</p><p><blockquote>医疗保险和医疗补助服务中心发布了一项单独的规定，要求从政府卫生计划中获得资金的76,000家卫生机构和家庭卫生保健提供者的工作人员接种疫苗。一位高级政府官员表示，几家大型私人医疗保健组织实施了自己的任务，并实现了96%或更高的高疫苗接种率，而没有出现广泛的辞职。</blockquote></p><p> The White House sees the new requirements as a potent tool to winnow down the ranks of the tens of millions of Americans who have thus far refused to get a shot.</p><p><blockquote>白宫将新要求视为筛选迄今为止拒绝接种疫苗的数千万美国人的有力工具。</blockquote></p><p> For weeks, Biden ha&nbsp;sencouraged businesses not to wait&nbsp;for the OSHA rule to take effect. He has touted businesses that have already announced their own vaccine mandates and urged other companies to follow their lead.</p><p><blockquote>几周来，拜登一直鼓励企业不要等待OSHA规则生效。他吹捧那些已经宣布自己的疫苗授权的企业，并敦促其他公司效仿他们的做法。</blockquote></p><p> Administration officials say those efforts are paying off, with about 70% of the nation’s adults now fully vaccinated.</p><p><blockquote>政府官员表示，这些努力正在取得成效，目前全国约70%的成年人已完全接种疫苗。</blockquote></p><p></p><p> Walmart, the nation’s largest private employer, said in late July it was requiring all workers at its headquarters in Bentonville, Arkansas, as well as its managers who travel within the U.S., to be vaccinated against COVID-19 by Oct. 4. But the company had stopped short of requiring shots for its frontline workers.</p><p><blockquote>美国最大的私营雇主沃尔玛在7月下旬表示，要求其位于阿肯色州本顿维尔总部的所有员工以及在美国境内旅行的经理在10月4日之前接种新冠肺炎疫苗。但该公司并未要求一线员工注射疫苗。</blockquote></p><p> United Airlines required U.S. employees to get vaccinated or face termination. Only a very small number of its 67,000 workers refused to do so.</p><p><blockquote>美联航要求美国员工接种疫苗，否则将面临解雇。其67,000名工人中只有极少数人拒绝这样做。</blockquote></p><p> In August, Tyson Foods told its 120,000 U.S. workers that they must be vaccinated by Nov. 1. A week before that deadline, the company said 96% of its workforce was fully vaccinated.</p><p><blockquote>8月，泰森食品公司告诉其12万名美国工人，他们必须在11月1日之前接种疫苗。在截止日期前一周，该公司表示96%的员工已完全接种疫苗。</blockquote></p><p> However, some companies have expressed fear that some vaccine-hesitant workers might quit, leaving their workforces even thinner in what is already a tight labor market.</p><p><blockquote>然而，一些公司表示担心，一些对疫苗犹豫不决的工人可能会辞职，使他们的劳动力在本已紧张的劳动力市场中变得更加稀少。</blockquote></p><p> Several large business groups complained about the timing of the mandate. Retail groups worried that the requirement could disrupt their operations during the critical Christmas shopping period. Retailers and others also said it could worsen supply chain disruptions.</p><p><blockquote>几个大型商业团体抱怨这项授权的时机。零售集团担心这一要求可能会扰乱他们在关键的圣诞购物期间的运营。零售商和其他人也表示，这可能会加剧供应链中断。</blockquote></p><p> The National Retail Federation suggested that the new rules are not needed because the rolling average number of new daily cases in the U.S. has fallen by more than half since September.</p><p><blockquote>全国零售联合会表示，不需要新规则，因为自9月份以来，美国每日新增病例的滚动平均数量已下降一半以上。</blockquote></p><p> “Nevertheless, the Biden administration has chosen to declare an ‘emergency’ and impose burdensome new requirements on retailers during the crucial holiday shopping season,” said David French, a senior vice president for the trade group.</p><p><blockquote>该贸易组织高级副总裁戴维·弗伦奇表示：“尽管如此，拜登政府还是选择宣布进入‘紧急状态’，并在关键的假日购物季对零售商提出繁重的新要求。”</blockquote></p><p> The number of new COVID-19 infections in the U.S. is still falling from a summer surge caused by the highly contagious delta variant, but the rate of decline has slowed in recent weeks. The 7-day moving average is down 6% from two weeks ago, at more than 76,000 new cases and 1,200 deaths per day.</p><p><blockquote>美国新增COVID-19感染人数仍在从高传染性德尔塔变异毒株导致的夏季激增中下降，但最近几周下降速度有所放缓。7天移动平均线较两周前下降6%，每天新增病例超过76,000例，死亡1,200例。</blockquote></p><p> The earlier mandate on federal contractors led to demonstrations by opponents, including workers at a NASA rocket engine test site in Mississippi. Some said they are immune because they contracted COVID-19. Others said vaccines violated their religious beliefs and constitutional rights.</p><p><blockquote>早些时候对联邦承包商的授权导致了反对者的示威，其中包括密西西比州美国宇航局火箭发动机试验场的工人。一些人说他们有免疫力，因为他们感染了新冠肺炎病毒。其他人则表示，疫苗侵犯了他们的宗教信仰和宪法权利。</blockquote></p><p> “No one should be forced to take a medical treatment just to keep their job,” said Nyla Trumbach, an engineer at the site. “There’s years and years of experience and skill out here, and I just want anyone who’s watching to see what we stand to lose here if these people don’t keep their jobs.”</p><p><blockquote>“任何人都不应该仅仅为了保住工作而被迫接受治疗，”该网站的工程师尼拉·特朗巴赫(Nyla Trumbach)说。“这里有多年的经验和技能，我只是想让任何观看的人都知道，如果这些人不保住工作，我们会失去什么。”</blockquote></p><p> Dozens of groups sought meetings with administration officials toair their concernsand objections to likely provisions of the OSHA rule, including the U.S. Chamber of Commerce, the National Association of Manufacturers, the AFL-CIO and anti-vaccine organizations.</p><p><blockquote>数十个团体寻求与政府官员会面，表达他们对OSHA规则可能条款的担忧和反对，其中包括美国商会、全国制造商协会、AFL-CIO和反疫苗组织。</blockquote></p><p></p>","source":"lsy1603278176698","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US mandates vaccines or tests for big companies by Jan. 4<blockquote>美国要求大公司在1月4日之前接种疫苗或进行测试</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS mandates vaccines or tests for big companies by Jan. 4<blockquote>美国要求大公司在1月4日之前接种疫苗或进行测试</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Associated Press News</strong><span class=\"h-time small\">2021-11-04 23:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Tens of millions of Americans who work at companies with 100 or more employees will need to be fully vaccinated against COVID-19 by Jan. 4 or get tested for the virus weekly under government rules issued Thursday.</p><p><blockquote>根据周四发布的政府规定，在拥有100名或更多员工的公司工作的数千万美国人需要在1月4日之前全面接种COVID-19疫苗，或者每周接受病毒检测。</blockquote></p><p> The new requirements, which were first previewed by President Joe Biden in September, will apply to about 84 million workers at medium and large businesses, although it is not clear how many of those employees are unvaccinated.</p><p><blockquote>美国总统乔·拜登(Joe Biden)于9月份首次预览了这些新要求，将适用于大中型企业的约8400万名员工，尽管尚不清楚其中有多少员工未接种疫苗。</blockquote></p><p> The Occupational Safety and Health Administration regulations will force the companies to require that unvaccinated workers test negative for COVID-19 at least once a week and wear a mask while in the workplace.</p><p><blockquote>职业安全与健康管理局的规定将迫使公司要求未接种疫苗的工人每周至少进行一次新冠肺炎病毒检测呈阴性，并在工作场所佩戴口罩。</blockquote></p><p> OSHA left open the possibility of expanding the requirement to smaller businesses. It asked for public comment on whether employers with fewer than 100 employees could handle vaccination or testing programs.</p><p><blockquote>OSHA保留了将该要求扩展到小型企业的可能性。它就员工少于100人的雇主是否可以处理疫苗接种或检测项目征求公众意见。</blockquote></p><p> Tougher rules will apply to another 17 million people who work in nursing homes, hospitals and other facilities that receive money from Medicare and Medicaid. Those workers will not have an option for testing — they will need to be vaccinated.</p><p><blockquote>更严格的规定将适用于另外1700万在疗养院、医院和其他接受医疗保险和医疗补助的机构工作的人。这些工人将没有检测的选择——他们需要接种疫苗。</blockquote></p><p> Workers will be able to ask for exemptions on medical or religious grounds.</p><p><blockquote>工人将能够以医疗或宗教为由要求豁免。</blockquote></p><p> OSHA said companies that fail to comply with the regulations could face penalties of nearly $14,000 per violation.</p><p><blockquote>OSHA表示，不遵守规定的公司每次违规可能面临近14,000美元的罚款。</blockquote></p><p> It was unclear how OSHA planned to enforce the rules: Even counting allied regulators at the state level, the agency&nbsp;has only 1,850 inspectors&nbsp;to oversee 130 million workers at 8 million workplaces. A senior administration official said OSHA will target companies if it gets complaints.</p><p><blockquote>目前尚不清楚OSHA计划如何执行这些规则：即使算上州一级的联合监管机构，该机构也只有1,850名检查员来监管800万个工作场所的1.3亿名工人。一名高级政府官员表示，如果收到投诉，OSHA将针对公司。</blockquote></p><p> The release of the rules followed weeks of regulatory review and meetings with business groups, labor unions and others. The regulations form the cornerstone of Biden’s most aggressive effort yet to combat the spread of COVID-19, which has killed more than 740,000 people in the U.S.</p><p><blockquote>这些规则是在经过数周的监管审查以及与商业团体、工会和其他人的会议之后发布的。这些规定是拜登迄今为止最积极努力抗击COVID-19传播的基石，该病毒已在美国造成超过74万人死亡。</blockquote></p><p> OSHA drafted the rules under emergency authority meant to protect workers from an imminent health hazard. The agency estimated that the vaccine mandate will save more than 6,500 worker lives and prevent more than 250,000 hospitalizations over the next six months.</p><p><blockquote>OSHA根据紧急授权起草了这些规则，旨在保护工人免受迫在眉睫的健康危害。该机构估计，疫苗授权将在未来六个月内挽救6,500多名工人的生命，并防止超过250,000人住院。</blockquote></p><p> Senior administration officials said the rules preempt conflicting state laws or orders, including those that ban employers from requiring vaccinations, testing or the wearing of face masks.</p><p><blockquote>高级政府官员表示，这些规定优先于相互冲突的州法律或命令，包括那些禁止雇主要求接种疫苗、检测或戴口罩的法律或命令。</blockquote></p><p> The administration will face an immediate challenge from Republican state officials who are eager to fight Biden in court and in Congress. Senate Republicans immediately launched a petition to force a vote to overturn the vaccine mandate, but with Democrats controlling the chamber, the effort is nearly certain to fail.</p><p><blockquote>政府将立即面临共和党州官员的挑战，他们渴望在法庭和国会与拜登对抗。参议院共和党人立即发起请愿，要求投票推翻疫苗授权，但由于民主党控制了众议院，这一努力几乎肯定会失败。</blockquote></p><p> More than two dozen Republicans serving as state attorneys general have indicated they plan to sue, arguing that only Congress can enact such sweeping requirements under emergency authority.</p><p><blockquote>二十多名担任州总检察长的共和党人表示，他们计划提起诉讼，认为只有国会才能根据紧急权力制定如此全面的要求。</blockquote></p><p> Last week, 19 states sued to stop Biden’s narrower mandate that employees of federal contractors be vaccinated. That requirement was scheduled to take effect Dec. 8, but the administration said Thursday it will be delayed until Jan. 4 to match the requirements on other large employers and health care providers.</p><p><blockquote>上周，19个州提起诉讼，要求阻止拜登对联邦承包商员工接种疫苗的狭隘要求。该要求原定于12月8日生效，但政府周四表示，将推迟到1月4日，以符合其他大型雇主和医疗保健提供商的要求。</blockquote></p><p> The&nbsp;rules&nbsp;will require workers to receive either two doses of the Pfizer or Moderna vaccines or one dose of the Johnson &amp; Johnson vaccine by Jan. 4 or be tested weekly. Employees who test positive must be removed from the workplace.</p><p><blockquote>这些规定将要求工人在1月4日之前接受两剂辉瑞或Moderna疫苗或一剂强生疫苗，或者每周接受一次检测。检测呈阳性的员工必须被带离工作场所。</blockquote></p><p> The requirements will not apply to people who work at home or outdoors.</p><p><blockquote>这些要求不适用于在家或户外工作的人。</blockquote></p><p> Companies won’t be required to provide or pay for the tests, but they must give paid time off for employees to get vaccines and sick leave to recover from side effects that prevent them from working. The requirements for masks and paid time off for shots will take effect Dec. 5.</p><p><blockquote>公司不会被要求提供或支付测试费用，但他们必须给员工带薪休假来接种疫苗和病假，以从阻止他们工作的副作用中恢复过来。戴口罩和带薪休假的要求将于12月5日生效。</blockquote></p><p> The Centers for Medicare &amp; Medicaid Services issued a separate rule requiring vaccination for workers in 76,000 health facilities and home health care providers that get funding from the government health programs. A senior administration official said that several large private health care organizations imposed their own mandates and achieved high vaccination rates — 96% or higher — without widespread resignations.</p><p><blockquote>医疗保险和医疗补助服务中心发布了一项单独的规定，要求从政府卫生计划中获得资金的76,000家卫生机构和家庭卫生保健提供者的工作人员接种疫苗。一位高级政府官员表示，几家大型私人医疗保健组织实施了自己的任务，并实现了96%或更高的高疫苗接种率，而没有出现广泛的辞职。</blockquote></p><p> The White House sees the new requirements as a potent tool to winnow down the ranks of the tens of millions of Americans who have thus far refused to get a shot.</p><p><blockquote>白宫将新要求视为筛选迄今为止拒绝接种疫苗的数千万美国人的有力工具。</blockquote></p><p> For weeks, Biden ha&nbsp;sencouraged businesses not to wait&nbsp;for the OSHA rule to take effect. He has touted businesses that have already announced their own vaccine mandates and urged other companies to follow their lead.</p><p><blockquote>几周来，拜登一直鼓励企业不要等待OSHA规则生效。他吹捧那些已经宣布自己的疫苗授权的企业，并敦促其他公司效仿他们的做法。</blockquote></p><p> Administration officials say those efforts are paying off, with about 70% of the nation’s adults now fully vaccinated.</p><p><blockquote>政府官员表示，这些努力正在取得成效，目前全国约70%的成年人已完全接种疫苗。</blockquote></p><p></p><p> Walmart, the nation’s largest private employer, said in late July it was requiring all workers at its headquarters in Bentonville, Arkansas, as well as its managers who travel within the U.S., to be vaccinated against COVID-19 by Oct. 4. But the company had stopped short of requiring shots for its frontline workers.</p><p><blockquote>美国最大的私营雇主沃尔玛在7月下旬表示，要求其位于阿肯色州本顿维尔总部的所有员工以及在美国境内旅行的经理在10月4日之前接种新冠肺炎疫苗。但该公司并未要求一线员工注射疫苗。</blockquote></p><p> United Airlines required U.S. employees to get vaccinated or face termination. Only a very small number of its 67,000 workers refused to do so.</p><p><blockquote>美联航要求美国员工接种疫苗，否则将面临解雇。其67,000名工人中只有极少数人拒绝这样做。</blockquote></p><p> In August, Tyson Foods told its 120,000 U.S. workers that they must be vaccinated by Nov. 1. A week before that deadline, the company said 96% of its workforce was fully vaccinated.</p><p><blockquote>8月，泰森食品公司告诉其12万名美国工人，他们必须在11月1日之前接种疫苗。在截止日期前一周，该公司表示96%的员工已完全接种疫苗。</blockquote></p><p> However, some companies have expressed fear that some vaccine-hesitant workers might quit, leaving their workforces even thinner in what is already a tight labor market.</p><p><blockquote>然而，一些公司表示担心，一些对疫苗犹豫不决的工人可能会辞职，使他们的劳动力在本已紧张的劳动力市场中变得更加稀少。</blockquote></p><p> Several large business groups complained about the timing of the mandate. Retail groups worried that the requirement could disrupt their operations during the critical Christmas shopping period. Retailers and others also said it could worsen supply chain disruptions.</p><p><blockquote>几个大型商业团体抱怨这项授权的时机。零售集团担心这一要求可能会扰乱他们在关键的圣诞购物期间的运营。零售商和其他人也表示，这可能会加剧供应链中断。</blockquote></p><p> The National Retail Federation suggested that the new rules are not needed because the rolling average number of new daily cases in the U.S. has fallen by more than half since September.</p><p><blockquote>全国零售联合会表示，不需要新规则，因为自9月份以来，美国每日新增病例的滚动平均数量已下降一半以上。</blockquote></p><p> “Nevertheless, the Biden administration has chosen to declare an ‘emergency’ and impose burdensome new requirements on retailers during the crucial holiday shopping season,” said David French, a senior vice president for the trade group.</p><p><blockquote>该贸易组织高级副总裁戴维·弗伦奇表示：“尽管如此，拜登政府还是选择宣布进入‘紧急状态’，并在关键的假日购物季对零售商提出繁重的新要求。”</blockquote></p><p> The number of new COVID-19 infections in the U.S. is still falling from a summer surge caused by the highly contagious delta variant, but the rate of decline has slowed in recent weeks. The 7-day moving average is down 6% from two weeks ago, at more than 76,000 new cases and 1,200 deaths per day.</p><p><blockquote>美国新增COVID-19感染人数仍在从高传染性德尔塔变异毒株导致的夏季激增中下降，但最近几周下降速度有所放缓。7天移动平均线较两周前下降6%，每天新增病例超过76,000例，死亡1,200例。</blockquote></p><p> The earlier mandate on federal contractors led to demonstrations by opponents, including workers at a NASA rocket engine test site in Mississippi. Some said they are immune because they contracted COVID-19. Others said vaccines violated their religious beliefs and constitutional rights.</p><p><blockquote>早些时候对联邦承包商的授权导致了反对者的示威，其中包括密西西比州美国宇航局火箭发动机试验场的工人。一些人说他们有免疫力，因为他们感染了新冠肺炎病毒。其他人则表示，疫苗侵犯了他们的宗教信仰和宪法权利。</blockquote></p><p> “No one should be forced to take a medical treatment just to keep their job,” said Nyla Trumbach, an engineer at the site. “There’s years and years of experience and skill out here, and I just want anyone who’s watching to see what we stand to lose here if these people don’t keep their jobs.”</p><p><blockquote>“任何人都不应该仅仅为了保住工作而被迫接受治疗，”该网站的工程师尼拉·特朗巴赫(Nyla Trumbach)说。“这里有多年的经验和技能，我只是想让任何观看的人都知道，如果这些人不保住工作，我们会失去什么。”</blockquote></p><p> Dozens of groups sought meetings with administration officials toair their concernsand objections to likely provisions of the OSHA rule, including the U.S. Chamber of Commerce, the National Association of Manufacturers, the AFL-CIO and anti-vaccine organizations.</p><p><blockquote>数十个团体寻求与政府官员会面，表达他们对OSHA规则可能条款的担忧和反对，其中包括美国商会、全国制造商协会、AFL-CIO和反疫苗组织。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://apnews.com/article/covid-employer-mandates-us-29c2262c336bcfc38da2d14b251daf51\">Associated Press News</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://apnews.com/article/covid-employer-mandates-us-29c2262c336bcfc38da2d14b251daf51","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198892706","content_text":"Tens of millions of Americans who work at companies with 100 or more employees will need to be fully vaccinated against COVID-19 by Jan. 4 or get tested for the virus weekly under government rules issued Thursday.\nThe new requirements, which were first previewed by President Joe Biden in September, will apply to about 84 million workers at medium and large businesses, although it is not clear how many of those employees are unvaccinated.\nThe Occupational Safety and Health Administration regulations will force the companies to require that unvaccinated workers test negative for COVID-19 at least once a week and wear a mask while in the workplace.\nOSHA left open the possibility of expanding the requirement to smaller businesses. It asked for public comment on whether employers with fewer than 100 employees could handle vaccination or testing programs.\nTougher rules will apply to another 17 million people who work in nursing homes, hospitals and other facilities that receive money from Medicare and Medicaid. Those workers will not have an option for testing — they will need to be vaccinated.\nWorkers will be able to ask for exemptions on medical or religious grounds.\nOSHA said companies that fail to comply with the regulations could face penalties of nearly $14,000 per violation.\nIt was unclear how OSHA planned to enforce the rules: Even counting allied regulators at the state level, the agency has only 1,850 inspectors to oversee 130 million workers at 8 million workplaces. A senior administration official said OSHA will target companies if it gets complaints.\nThe release of the rules followed weeks of regulatory review and meetings with business groups, labor unions and others. The regulations form the cornerstone of Biden’s most aggressive effort yet to combat the spread of COVID-19, which has killed more than 740,000 people in the U.S.\nOSHA drafted the rules under emergency authority meant to protect workers from an imminent health hazard. The agency estimated that the vaccine mandate will save more than 6,500 worker lives and prevent more than 250,000 hospitalizations over the next six months.\nSenior administration officials said the rules preempt conflicting state laws or orders, including those that ban employers from requiring vaccinations, testing or the wearing of face masks.\nThe administration will face an immediate challenge from Republican state officials who are eager to fight Biden in court and in Congress. Senate Republicans immediately launched a petition to force a vote to overturn the vaccine mandate, but with Democrats controlling the chamber, the effort is nearly certain to fail.\nMore than two dozen Republicans serving as state attorneys general have indicated they plan to sue, arguing that only Congress can enact such sweeping requirements under emergency authority.\nLast week, 19 states sued to stop Biden’s narrower mandate that employees of federal contractors be vaccinated. That requirement was scheduled to take effect Dec. 8, but the administration said Thursday it will be delayed until Jan. 4 to match the requirements on other large employers and health care providers.\nThe rules will require workers to receive either two doses of the Pfizer or Moderna vaccines or one dose of the Johnson & Johnson vaccine by Jan. 4 or be tested weekly. Employees who test positive must be removed from the workplace.\nThe requirements will not apply to people who work at home or outdoors.\nCompanies won’t be required to provide or pay for the tests, but they must give paid time off for employees to get vaccines and sick leave to recover from side effects that prevent them from working. The requirements for masks and paid time off for shots will take effect Dec. 5.\nThe Centers for Medicare & Medicaid Services issued a separate rule requiring vaccination for workers in 76,000 health facilities and home health care providers that get funding from the government health programs. A senior administration official said that several large private health care organizations imposed their own mandates and achieved high vaccination rates — 96% or higher — without widespread resignations.\nThe White House sees the new requirements as a potent tool to winnow down the ranks of the tens of millions of Americans who have thus far refused to get a shot.\nFor weeks, Biden ha sencouraged businesses not to wait for the OSHA rule to take effect. He has touted businesses that have already announced their own vaccine mandates and urged other companies to follow their lead.\nAdministration officials say those efforts are paying off, with about 70% of the nation’s adults now fully vaccinated.\nWalmart, the nation’s largest private employer, said in late July it was requiring all workers at its headquarters in Bentonville, Arkansas, as well as its managers who travel within the U.S., to be vaccinated against COVID-19 by Oct. 4. But the company had stopped short of requiring shots for its frontline workers.\nUnited Airlines required U.S. employees to get vaccinated or face termination. Only a very small number of its 67,000 workers refused to do so.\nIn August, Tyson Foods told its 120,000 U.S. workers that they must be vaccinated by Nov. 1. A week before that deadline, the company said 96% of its workforce was fully vaccinated.\nHowever, some companies have expressed fear that some vaccine-hesitant workers might quit, leaving their workforces even thinner in what is already a tight labor market.\nSeveral large business groups complained about the timing of the mandate. Retail groups worried that the requirement could disrupt their operations during the critical Christmas shopping period. Retailers and others also said it could worsen supply chain disruptions.\nThe National Retail Federation suggested that the new rules are not needed because the rolling average number of new daily cases in the U.S. has fallen by more than half since September.\n“Nevertheless, the Biden administration has chosen to declare an ‘emergency’ and impose burdensome new requirements on retailers during the crucial holiday shopping season,” said David French, a senior vice president for the trade group.\nThe number of new COVID-19 infections in the U.S. is still falling from a summer surge caused by the highly contagious delta variant, but the rate of decline has slowed in recent weeks. The 7-day moving average is down 6% from two weeks ago, at more than 76,000 new cases and 1,200 deaths per day.\nThe earlier mandate on federal contractors led to demonstrations by opponents, including workers at a NASA rocket engine test site in Mississippi. Some said they are immune because they contracted COVID-19. Others said vaccines violated their religious beliefs and constitutional rights.\n“No one should be forced to take a medical treatment just to keep their job,” said Nyla Trumbach, an engineer at the site. “There’s years and years of experience and skill out here, and I just want anyone who’s watching to see what we stand to lose here if these people don’t keep their jobs.”\nDozens of groups sought meetings with administration officials toair their concernsand objections to likely provisions of the OSHA rule, including the U.S. Chamber of Commerce, the National Association of Manufacturers, the AFL-CIO and anti-vaccine organizations.","news_type":1,"symbols_score_info":{".IXIC":0.9,".DJI":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846193570,"gmtCreate":1636066084373,"gmtModify":1636066085057,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看跌]&nbsp;[看跌]&nbsp;[看跌]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看跌]&nbsp;[看跌]&nbsp;[看跌]&nbsp;","text":"$Pfizer(PFE)$[看跌] [看跌] [看跌]","images":[{"img":"https://static.tigerbbs.com/6af65a7651d317e785a48463737da5d3","width":"1080","height":"2259"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846193570","isVote":1,"tweetType":1,"viewCount":1079,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":841386631,"gmtCreate":1635889023153,"gmtModify":1635889023379,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>sold at$ $45.65","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>sold at$ $45.65","text":"$Pfizer(PFE)$sold at$ $45.65","images":[{"img":"https://static.tigerbbs.com/b3c90cc907a822d84b0f6faa7b45a9d1","width":"1080","height":"2259"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841386631","isVote":1,"tweetType":1,"viewCount":692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":843967103,"gmtCreate":1635802490398,"gmtModify":1635802490608,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[捂脸]&nbsp;","text":"$Tesla Motors(TSLA)$[捂脸]","images":[{"img":"https://static.tigerbbs.com/e49c37c0bc271f97347002e0bf7a52d6","width":"1080","height":"2259"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843967103","isVote":1,"tweetType":1,"viewCount":1110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":843967053,"gmtCreate":1635802465903,"gmtModify":1635802466154,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Pfizer(PFE)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/d0507d4934b9dce7552ec60c25d30ec6","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843967053","isVote":1,"tweetType":1,"viewCount":731,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":849614661,"gmtCreate":1635751608169,"gmtModify":1635751608398,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582450584533032","idStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Pfizer(PFE)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/2598c8ee72a06044f6b7b3c171fb0c26","width":"1080","height":"2259"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849614661","isVote":1,"tweetType":1,"viewCount":922,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":187434860,"gmtCreate":1623761586250,"gmtModify":1631892957542,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Apple(AAPL)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/210d4ca9a62ba8be068a7e025a736737","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/187434860","isVote":1,"tweetType":1,"viewCount":486,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":133182445,"gmtCreate":1621728085387,"gmtModify":1631892957553,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[捂脸]&nbsp;[流泪]&nbsp;when is it going to move up????","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[捂脸]&nbsp;[流泪]&nbsp;when is it going to move up????","text":"$Apple(AAPL)$[捂脸] [流泪] when is it going to move up????","images":[{"img":"https://static.tigerbbs.com/af1ce2b0ef4b78dcf19ba7553e64c1d3","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/133182445","isVote":1,"tweetType":1,"viewCount":477,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":801859602,"gmtCreate":1627511221106,"gmtModify":1631892957581,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Pfizer(PFE)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/a4090ca8f47bc1dfb4cac87b877e8a69","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/801859602","isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":121313749,"gmtCreate":1624453568181,"gmtModify":1631892957589,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Pfizer(PFE)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/6a32bb65cb61ddd7bb7f8e0bbb1e6e92","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/121313749","isVote":1,"tweetType":1,"viewCount":383,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":847348082,"gmtCreate":1636497875885,"gmtModify":1636497876562,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"Bad news for the market.&nbsp;","listText":"Bad news for the market.&nbsp;","text":"Bad news for the market.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/847348082","repostId":"1127189501","repostType":2,"isVote":1,"tweetType":1,"viewCount":2411,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":882949050,"gmtCreate":1631657511570,"gmtModify":1631883821434,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"Apple is very greedy......","listText":"Apple is very greedy......","text":"Apple is very greedy......","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882949050","repostId":"1147706594","repostType":4,"repost":{"id":"1147706594","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631639765,"share":"https://www.laohu8.com/m/news/1147706594?lang=zh_CN&edition=full","pubTime":"2021-09-15 01:16","market":"other","language":"en","title":"Apple unveils iPhone 13, new iPads and Apple Watch<blockquote>苹果推出iPhone 13、新款iPad和苹果手表</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1147706594","media":"Tiger Newspress","summary":"Apple CEO Tim Cook moved onto product announcements, starting with a new iPad. The video was recorded in an empty auditorium.Apple’s lowest-cost iPad, simply called iPad, is getting an update with a faster A13 processor and a better, 12 megapixel front-facing camera for better video calls, like on Zoom. It’s got a wider lens to capture more people in a single scene and can have an LTE wireless connection.Apple also announced a new iPad Mini, which has a smaller 8.3-inch screen. It has a redesign","content":"<p>Apple CEO Tim Cook moved onto product announcements, starting with a new iPad. The video was recorded in an empty auditorium.</p><p><blockquote>苹果首席执行官蒂姆·库克开始发布产品，首先是新款iPad。视频是在一个空荡荡的礼堂里录制的。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/26d6a31fbb7ecf29e9d253486d082a5b\" tg-width=\"630\" tg-height=\"354\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Apple’s lowest-cost iPad, simply called iPad, is getting an update with a faster A13 processor and a better, 12 megapixel front-facing camera for better video calls, like on Zoom. It’s got a wider lens to capture more people in a single scene and can have an LTE wireless connection.</p><p><blockquote>苹果成本最低的iPad，简称为iPad，正在进行更新，配备更快的A13处理器和更好的1200万像素前置摄像头，以获得更好的视频评级，如变焦。它有一个更宽的镜头，可以在一个场景中捕捉更多的人，并且可以有LTE无线连接。</blockquote></p><p> It costs $329 with 64GB of storage. That’s more storage but the same starting price as before. It goes on sale next week.</p><p><blockquote>64GB存储空间的价格为329美元。存储空间更大，但起价与以前相同。它下周开始销售。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2b24dbf81571b194598307fecee1b859\" tg-width=\"2102\" tg-height=\"1160\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Apple also announced a new iPad Mini, which has a smaller 8.3-inch screen. It has a redesign featuring new, flatter design language, like the iPhone 12. It has smaller bezels with no fingerprint sensor on the front and comes in several colors, including purple.</p><p><blockquote>苹果还宣布了一款新的iPad Mini，它的屏幕更小，为8.3英寸。它进行了重新设计，采用了新的、更扁平的设计语言，就像iPhone 12一样。它的边框较小，正面没有指纹传感器，有几种颜色，包括紫色。</blockquote></p><p> The TouchID sensor has been built into the top button, which turns the screen on and off. It uses an USB-C connector, instead of Apple’s proprietary Lightning connector. It can support a 5G wireless connection. It works with Apple’s stylus, the second-generation Pencil.</p><p><blockquote>TouchID传感器内置在顶部按钮中，可以打开和关闭屏幕。它使用USB-C连接器，而不是苹果专有的Lightning连接器。它可以支持5G无线连接。它与苹果的第二代铅笔手写笔配合使用。</blockquote></p><p> It starts at $499 and hits stores next week, Apple said.</p><p><blockquote>苹果说，它的起价为499美元，将于下周上市。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/08d5a621b63de3c432534e2c8818d294\" tg-width=\"2096\" tg-height=\"1200\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Apple announces new Apple Watch Series 7</b></p><p><blockquote><b>苹果发布新款苹果手表Series 7</b></blockquote></p><p> Apple’s next product reveal will be the Apple Watch models, Cook said. The specs are being announced by Apple COO Jeff Williams.</p><p><blockquote>苹果的下一个产品展示将是苹果手表模型。苹果首席运营官Jeff Williams宣布了这些规格。</blockquote></p><p> The new models are called Apple Watch Series 7 will have a redesign, according to a promotional video shown by Apple. The new models have 20% screen area over last year’s Series 6 models but retains an industrial design with rounded edges. Apple says the screen is more crack-resistant and it charges faster.</p><p><blockquote>根据苹果展示的宣传视频，名为苹果手表系列7的新型号将进行重新设计。新机型的屏幕面积比去年的Series 6机型增加了20%，但保留了圆形边缘的工业设计。苹果表示，屏幕更抗裂，充电速度更快。</blockquote></p><p> Apple has redesigned its software to fit more information on the screen, the company said. It comes several new watch faces.</p><p><blockquote>该公司表示，苹果已经重新设计了其软件，以适应屏幕上的更多信息。它有几个新的表盘。</blockquote></p><p> The entry-level model comes in five colors, including blue, and red. It also comes in aluminum, steel, and titanium cases, all of which have different prices.</p><p><blockquote>入门级型号有五种颜色，包括蓝色和红色。它也有铝、钢和钛外壳，所有这些都有不同的价格。</blockquote></p><p> Previous Apple Watch bands will still work with the new models, Apple said.</p><p><blockquote>苹果说，以前的苹果表带仍将适用于新型号。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/0a7f17f4717a866018f2cea4a1930f81\" tg-width=\"630\" tg-height=\"354\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Apple announces iPhone 13 with smaller notch and bigger battery</b></p><p><blockquote><b>苹果宣布iPhone 13采用更小的刘海和更大的电池</b></blockquote></p><p> With over 2 million viewers watching on YouTube, Apple CEO Tim Cook announced new iPhone models called iPhone 13.</p><p><blockquote>随着超过200万观众在YouTube上观看，苹果首席执行官蒂姆·库克宣布了名为iPhone 13的新iPhone型号。</blockquote></p><p> The iPhone 13 has a smaller display cutout, or \"notch,\" at the top of the screen.</p><p><blockquote>iPhone 13在屏幕顶部有一个更小的显示切口，或“凹口”。</blockquote></p><p> Otherwise, the new iPhone 13 mostly has the same design as last year with new camera modules arranged diagonally. One camera is a 12-megapixel wide-angle lens, with a big sensor that captures 50% more light, Apple said. The other lens is an ultra-wide lens.</p><p><blockquote>除此之外，新款iPhone 13的设计大多与去年相同，新的摄像头模块对角线排列。苹果说，一个摄像头是1200万像素的广角镜头，带有一个大传感器，可以多捕捉50%的光线。另一个镜头是超广角镜头。</blockquote></p><p> One camera improvement is a new \"cinematic mode\" that can hold focus on a moving subject.</p><p><blockquote>相机的一个改进是一种新的“电影模式”，可以将焦点放在移动的主体上。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/28421818b5ca117bc9c589e78ef8bda1\" tg-width=\"630\" tg-height=\"354\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> It also has a bigger battery and brighter screen, Apple said. It comes in two sizes, 5.4-inch, and 6.1-inches, and five colors.</p><p><blockquote>苹果说，它还拥有更大的电池和更亮的屏幕。它有两种尺寸，5.4英寸和6.1英寸，以及五种颜色。</blockquote></p><p> It has a new Apple-designed chip powering it, which the company is calling A15 Bionic. It has six cores and a specialized portion for running artificial intelligence algorithms.</p><p><blockquote>它有一个苹果设计的新芯片为其提供动力，该公司称之为A15 Bionic。它有六个核心和一个专门用于运行人工智能算法的部分。</blockquote></p><p> Like last year’s model, this year’s iPhones will have 5G connectivity. Apple says it works on carriers in 60 countries.</p><p><blockquote>与去年的型号一样，今年的iPhone将具有5G连接功能。苹果表示，它适用于60个国家的运营商。</blockquote></p><p> The iPhone 13 mini costs $699 and the iPhone 13 costs $799, Apple said, the same prices as last year. Devices now start with 128GB of storage space, an increase over last year.</p><p><blockquote>苹果表示，iPhone 13 mini的售价为699美元，iPhone 13的售价为799美元，与去年的价格相同。设备现在的起始存储空间为128GB，比去年有所增加。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7f1aaddad155334f27af83cd513064cb\" tg-width=\"630\" tg-height=\"354\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Apple announces high-end iPhone 13 Pro models with bigger batteries</b></p><p><blockquote><b>苹果宣布配备更大电池的高端iPhone 13 Pro机型</b></blockquote></p><p> Apple announced the iPhone 13 Pro and iPhone 13 Pro Max with longer battery life.</p><p><blockquote>苹果公布了续航更长的iPhone 13 Pro和iPhone 13 Pro Max。</blockquote></p><p> The iPhone 12 Pro should have a 1.5 hour longer battery life and its bigger sibling will have a 2.5 hour longer battery life, Apple said. The iPhone 13 Pro starts at $999 and the Pro Max starts at $1099, the same prices as last year. Apple also has added a larger 1TB storage option.</p><p><blockquote>苹果表示，iPhone 12 Pro的电池续航时间应该会延长1.5小时，而其更大的兄弟机型的电池续航时间会延长2.5小时。iPhone 13 Pro起售价为999美元，Pro Max起售价为1099美元，价格与去年持平。苹果还增加了更大的1TB存储选项。</blockquote></p><p> The new iPhones will go on sale on September 24, Apple said.</p><p><blockquote>苹果表示，新款iPhones将于9月24日上市。</blockquote></p><p> They have the same screen sizes as last year's models, with a 6.1-inch version and a bigger 6.7-inch version. This year's models also come in a \"Sierra Blue\" version.</p><p><blockquote>它们的屏幕尺寸与去年的型号相同，有6.1英寸版本和更大的6.7英寸版本。今年的车型还推出了“Sierra Blue”版本。</blockquote></p><p></p><p> The biggest distinguishing characteristic between iPhone's base models and its Pro models is that they have three rear-facing cameras, including a zoom lens, a wide lens, and an ultra-wide camera, which can focus on objects as close as 2 centimeters away.</p><p><blockquote>iPhone的基础机型和Pro机型最大的区别在于后置三颗摄像头，包括一颗变焦镜头、一颗广角镜头和一颗超广角镜头，可以对近至2厘米外的物体进行对焦。</blockquote></p><p> The iPhone 13 Pro has a display that Apple calls \"Super Retina XDR with ProMotion\" that has twice the refresh rate as previous iPhones. This means that scrolling on an iPhone should look smoother with less lag.</p><p><blockquote>iPhone 13 Pro的显示屏被苹果·评级称为“Super Retina XDR with ProMotion”，刷新率是以前iPhone的两倍。这意味着在iPhone上滚动应该看起来更流畅，延迟更少。</blockquote></p><p> The Pro models have the same chip as the main iPhones, the A15 Bionic, Apple said.</p><p><blockquote>苹果表示，Pro型号拥有与主要iPhone A15 Bionic相同的芯片。</blockquote></p><p> This year's models are still constructed out of stainless steel, Apple marketing chief Greg Jozwiak said.</p><p><blockquote>苹果营销主管Greg Jozwiak表示，今年的车型仍然由不锈钢制成。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b411f06b12d3389f607254c992313eb5\" tg-width=\"2078\" tg-height=\"1010\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple unveils iPhone 13, new iPads and Apple Watch<blockquote>苹果推出iPhone 13、新款iPad和苹果手表</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple unveils iPhone 13, new iPads and Apple Watch<blockquote>苹果推出iPhone 13、新款iPad和苹果手表</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-15 01:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Apple CEO Tim Cook moved onto product announcements, starting with a new iPad. The video was recorded in an empty auditorium.</p><p><blockquote>苹果首席执行官蒂姆·库克开始发布产品，首先是新款iPad。视频是在一个空荡荡的礼堂里录制的。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/26d6a31fbb7ecf29e9d253486d082a5b\" tg-width=\"630\" tg-height=\"354\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Apple’s lowest-cost iPad, simply called iPad, is getting an update with a faster A13 processor and a better, 12 megapixel front-facing camera for better video calls, like on Zoom. It’s got a wider lens to capture more people in a single scene and can have an LTE wireless connection.</p><p><blockquote>苹果成本最低的iPad，简称为iPad，正在进行更新，配备更快的A13处理器和更好的1200万像素前置摄像头，以获得更好的视频评级，如变焦。它有一个更宽的镜头，可以在一个场景中捕捉更多的人，并且可以有LTE无线连接。</blockquote></p><p> It costs $329 with 64GB of storage. That’s more storage but the same starting price as before. It goes on sale next week.</p><p><blockquote>64GB存储空间的价格为329美元。存储空间更大，但起价与以前相同。它下周开始销售。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2b24dbf81571b194598307fecee1b859\" tg-width=\"2102\" tg-height=\"1160\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Apple also announced a new iPad Mini, which has a smaller 8.3-inch screen. It has a redesign featuring new, flatter design language, like the iPhone 12. It has smaller bezels with no fingerprint sensor on the front and comes in several colors, including purple.</p><p><blockquote>苹果还宣布了一款新的iPad Mini，它的屏幕更小，为8.3英寸。它进行了重新设计，采用了新的、更扁平的设计语言，就像iPhone 12一样。它的边框较小，正面没有指纹传感器，有几种颜色，包括紫色。</blockquote></p><p> The TouchID sensor has been built into the top button, which turns the screen on and off. It uses an USB-C connector, instead of Apple’s proprietary Lightning connector. It can support a 5G wireless connection. It works with Apple’s stylus, the second-generation Pencil.</p><p><blockquote>TouchID传感器内置在顶部按钮中，可以打开和关闭屏幕。它使用USB-C连接器，而不是苹果专有的Lightning连接器。它可以支持5G无线连接。它与苹果的第二代铅笔手写笔配合使用。</blockquote></p><p> It starts at $499 and hits stores next week, Apple said.</p><p><blockquote>苹果说，它的起价为499美元，将于下周上市。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/08d5a621b63de3c432534e2c8818d294\" tg-width=\"2096\" tg-height=\"1200\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Apple announces new Apple Watch Series 7</b></p><p><blockquote><b>苹果发布新款苹果手表Series 7</b></blockquote></p><p> Apple’s next product reveal will be the Apple Watch models, Cook said. The specs are being announced by Apple COO Jeff Williams.</p><p><blockquote>苹果的下一个产品展示将是苹果手表模型。苹果首席运营官Jeff Williams宣布了这些规格。</blockquote></p><p> The new models are called Apple Watch Series 7 will have a redesign, according to a promotional video shown by Apple. The new models have 20% screen area over last year’s Series 6 models but retains an industrial design with rounded edges. Apple says the screen is more crack-resistant and it charges faster.</p><p><blockquote>根据苹果展示的宣传视频，名为苹果手表系列7的新型号将进行重新设计。新机型的屏幕面积比去年的Series 6机型增加了20%，但保留了圆形边缘的工业设计。苹果表示，屏幕更抗裂，充电速度更快。</blockquote></p><p> Apple has redesigned its software to fit more information on the screen, the company said. It comes several new watch faces.</p><p><blockquote>该公司表示，苹果已经重新设计了其软件，以适应屏幕上的更多信息。它有几个新的表盘。</blockquote></p><p> The entry-level model comes in five colors, including blue, and red. It also comes in aluminum, steel, and titanium cases, all of which have different prices.</p><p><blockquote>入门级型号有五种颜色，包括蓝色和红色。它也有铝、钢和钛外壳，所有这些都有不同的价格。</blockquote></p><p> Previous Apple Watch bands will still work with the new models, Apple said.</p><p><blockquote>苹果说，以前的苹果表带仍将适用于新型号。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/0a7f17f4717a866018f2cea4a1930f81\" tg-width=\"630\" tg-height=\"354\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Apple announces iPhone 13 with smaller notch and bigger battery</b></p><p><blockquote><b>苹果宣布iPhone 13采用更小的刘海和更大的电池</b></blockquote></p><p> With over 2 million viewers watching on YouTube, Apple CEO Tim Cook announced new iPhone models called iPhone 13.</p><p><blockquote>随着超过200万观众在YouTube上观看，苹果首席执行官蒂姆·库克宣布了名为iPhone 13的新iPhone型号。</blockquote></p><p> The iPhone 13 has a smaller display cutout, or \"notch,\" at the top of the screen.</p><p><blockquote>iPhone 13在屏幕顶部有一个更小的显示切口，或“凹口”。</blockquote></p><p> Otherwise, the new iPhone 13 mostly has the same design as last year with new camera modules arranged diagonally. One camera is a 12-megapixel wide-angle lens, with a big sensor that captures 50% more light, Apple said. The other lens is an ultra-wide lens.</p><p><blockquote>除此之外，新款iPhone 13的设计大多与去年相同，新的摄像头模块对角线排列。苹果说，一个摄像头是1200万像素的广角镜头，带有一个大传感器，可以多捕捉50%的光线。另一个镜头是超广角镜头。</blockquote></p><p> One camera improvement is a new \"cinematic mode\" that can hold focus on a moving subject.</p><p><blockquote>相机的一个改进是一种新的“电影模式”，可以将焦点放在移动的主体上。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/28421818b5ca117bc9c589e78ef8bda1\" tg-width=\"630\" tg-height=\"354\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> It also has a bigger battery and brighter screen, Apple said. It comes in two sizes, 5.4-inch, and 6.1-inches, and five colors.</p><p><blockquote>苹果说，它还拥有更大的电池和更亮的屏幕。它有两种尺寸，5.4英寸和6.1英寸，以及五种颜色。</blockquote></p><p> It has a new Apple-designed chip powering it, which the company is calling A15 Bionic. It has six cores and a specialized portion for running artificial intelligence algorithms.</p><p><blockquote>它有一个苹果设计的新芯片为其提供动力，该公司称之为A15 Bionic。它有六个核心和一个专门用于运行人工智能算法的部分。</blockquote></p><p> Like last year’s model, this year’s iPhones will have 5G connectivity. Apple says it works on carriers in 60 countries.</p><p><blockquote>与去年的型号一样，今年的iPhone将具有5G连接功能。苹果表示，它适用于60个国家的运营商。</blockquote></p><p> The iPhone 13 mini costs $699 and the iPhone 13 costs $799, Apple said, the same prices as last year. Devices now start with 128GB of storage space, an increase over last year.</p><p><blockquote>苹果表示，iPhone 13 mini的售价为699美元，iPhone 13的售价为799美元，与去年的价格相同。设备现在的起始存储空间为128GB，比去年有所增加。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7f1aaddad155334f27af83cd513064cb\" tg-width=\"630\" tg-height=\"354\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Apple announces high-end iPhone 13 Pro models with bigger batteries</b></p><p><blockquote><b>苹果宣布配备更大电池的高端iPhone 13 Pro机型</b></blockquote></p><p> Apple announced the iPhone 13 Pro and iPhone 13 Pro Max with longer battery life.</p><p><blockquote>苹果公布了续航更长的iPhone 13 Pro和iPhone 13 Pro Max。</blockquote></p><p> The iPhone 12 Pro should have a 1.5 hour longer battery life and its bigger sibling will have a 2.5 hour longer battery life, Apple said. The iPhone 13 Pro starts at $999 and the Pro Max starts at $1099, the same prices as last year. Apple also has added a larger 1TB storage option.</p><p><blockquote>苹果表示，iPhone 12 Pro的电池续航时间应该会延长1.5小时，而其更大的兄弟机型的电池续航时间会延长2.5小时。iPhone 13 Pro起售价为999美元，Pro Max起售价为1099美元，价格与去年持平。苹果还增加了更大的1TB存储选项。</blockquote></p><p> The new iPhones will go on sale on September 24, Apple said.</p><p><blockquote>苹果表示，新款iPhones将于9月24日上市。</blockquote></p><p> They have the same screen sizes as last year's models, with a 6.1-inch version and a bigger 6.7-inch version. This year's models also come in a \"Sierra Blue\" version.</p><p><blockquote>它们的屏幕尺寸与去年的型号相同，有6.1英寸版本和更大的6.7英寸版本。今年的车型还推出了“Sierra Blue”版本。</blockquote></p><p></p><p> The biggest distinguishing characteristic between iPhone's base models and its Pro models is that they have three rear-facing cameras, including a zoom lens, a wide lens, and an ultra-wide camera, which can focus on objects as close as 2 centimeters away.</p><p><blockquote>iPhone的基础机型和Pro机型最大的区别在于后置三颗摄像头，包括一颗变焦镜头、一颗广角镜头和一颗超广角镜头，可以对近至2厘米外的物体进行对焦。</blockquote></p><p> The iPhone 13 Pro has a display that Apple calls \"Super Retina XDR with ProMotion\" that has twice the refresh rate as previous iPhones. This means that scrolling on an iPhone should look smoother with less lag.</p><p><blockquote>iPhone 13 Pro的显示屏被苹果·评级称为“Super Retina XDR with ProMotion”，刷新率是以前iPhone的两倍。这意味着在iPhone上滚动应该看起来更流畅，延迟更少。</blockquote></p><p> The Pro models have the same chip as the main iPhones, the A15 Bionic, Apple said.</p><p><blockquote>苹果表示，Pro型号拥有与主要iPhone A15 Bionic相同的芯片。</blockquote></p><p> This year's models are still constructed out of stainless steel, Apple marketing chief Greg Jozwiak said.</p><p><blockquote>苹果营销主管Greg Jozwiak表示，今年的车型仍然由不锈钢制成。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b411f06b12d3389f607254c992313eb5\" tg-width=\"2078\" tg-height=\"1010\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/13f224bb016b853641f590b6753763d1","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147706594","content_text":"Apple CEO Tim Cook moved onto product announcements, starting with a new iPad. The video was recorded in an empty auditorium.\n\nApple’s lowest-cost iPad, simply called iPad, is getting an update with a faster A13 processor and a better, 12 megapixel front-facing camera for better video calls, like on Zoom. It’s got a wider lens to capture more people in a single scene and can have an LTE wireless connection.\nIt costs $329 with 64GB of storage. That’s more storage but the same starting price as before. It goes on sale next week.\n\nApple also announced a new iPad Mini, which has a smaller 8.3-inch screen. It has a redesign featuring new, flatter design language, like the iPhone 12. It has smaller bezels with no fingerprint sensor on the front and comes in several colors, including purple.\nThe TouchID sensor has been built into the top button, which turns the screen on and off. It uses an USB-C connector, instead of Apple’s proprietary Lightning connector. It can support a 5G wireless connection. It works with Apple’s stylus, the second-generation Pencil.\nIt starts at $499 and hits stores next week, Apple said.\n\nApple announces new Apple Watch Series 7\nApple’s next product reveal will be the Apple Watch models, Cook said. The specs are being announced by Apple COO Jeff Williams.\nThe new models are called Apple Watch Series 7 will have a redesign, according to a promotional video shown by Apple. The new models have 20% screen area over last year’s Series 6 models but retains an industrial design with rounded edges. Apple says the screen is more crack-resistant and it charges faster.\nApple has redesigned its software to fit more information on the screen, the company said. It comes several new watch faces.\nThe entry-level model comes in five colors, including blue, and red. It also comes in aluminum, steel, and titanium cases, all of which have different prices.\nPrevious Apple Watch bands will still work with the new models, Apple said.\n\nApple announces iPhone 13 with smaller notch and bigger battery\nWith over 2 million viewers watching on YouTube, Apple CEO Tim Cook announced new iPhone models called iPhone 13.\nThe iPhone 13 has a smaller display cutout, or \"notch,\" at the top of the screen.\nOtherwise, the new iPhone 13 mostly has the same design as last year with new camera modules arranged diagonally. One camera is a 12-megapixel wide-angle lens, with a big sensor that captures 50% more light, Apple said. The other lens is an ultra-wide lens.\nOne camera improvement is a new \"cinematic mode\" that can hold focus on a moving subject.\n\nIt also has a bigger battery and brighter screen, Apple said. It comes in two sizes, 5.4-inch, and 6.1-inches, and five colors.\nIt has a new Apple-designed chip powering it, which the company is calling A15 Bionic. It has six cores and a specialized portion for running artificial intelligence algorithms.\nLike last year’s model, this year’s iPhones will have 5G connectivity. Apple says it works on carriers in 60 countries.\nThe iPhone 13 mini costs $699 and the iPhone 13 costs $799, Apple said, the same prices as last year. Devices now start with 128GB of storage space, an increase over last year.\n\nApple announces high-end iPhone 13 Pro models with bigger batteries\nApple announced the iPhone 13 Pro and iPhone 13 Pro Max with longer battery life.\nThe iPhone 12 Pro should have a 1.5 hour longer battery life and its bigger sibling will have a 2.5 hour longer battery life, Apple said. The iPhone 13 Pro starts at $999 and the Pro Max starts at $1099, the same prices as last year. Apple also has added a larger 1TB storage option.\nThe new iPhones will go on sale on September 24, Apple said.\nThey have the same screen sizes as last year's models, with a 6.1-inch version and a bigger 6.7-inch version. This year's models also come in a \"Sierra Blue\" version.\nThe biggest distinguishing characteristic between iPhone's base models and its Pro models is that they have three rear-facing cameras, including a zoom lens, a wide lens, and an ultra-wide camera, which can focus on objects as close as 2 centimeters away.\nThe iPhone 13 Pro has a display that Apple calls \"Super Retina XDR with ProMotion\" that has twice the refresh rate as previous iPhones. This means that scrolling on an iPhone should look smoother with less lag.\nThe Pro models have the same chip as the main iPhones, the A15 Bionic, Apple said.\nThis year's models are still constructed out of stainless steel, Apple marketing chief Greg Jozwiak said.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832202776,"gmtCreate":1629633013995,"gmtModify":1631892957600,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"[惊讶]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"[惊讶]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"[惊讶] [看涨] [看涨] [看涨]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/832202776","repostId":"1133515985","repostType":2,"isVote":1,"tweetType":1,"viewCount":688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":831108223,"gmtCreate":1629293476662,"gmtModify":1631885478904,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INTC\">$Intel(INTC)$</a>[捂脸]&nbsp;[捂脸]&nbsp;[喷血]&nbsp;","listText":"<a href=\"https://laohu8.com/S/INTC\">$Intel(INTC)$</a>[捂脸]&nbsp;[捂脸]&nbsp;[喷血]&nbsp;","text":"$Intel(INTC)$[捂脸] [捂脸] [喷血]","images":[{"img":"https://static.tigerbbs.com/3be4c87466dde024c5f669660c455424","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/831108223","isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":174489930,"gmtCreate":1627125988220,"gmtModify":1631892957616,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>better luck next week.&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>better luck next week.&nbsp;","text":"$Pfizer(PFE)$better luck next week.","images":[{"img":"https://static.tigerbbs.com/3d6fae3e6fb06753cce7f7c848e7f647","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/174489930","isVote":1,"tweetType":1,"viewCount":433,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":158440346,"gmtCreate":1625178888085,"gmtModify":1631892957625,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[贱笑]&nbsp;[贱笑]&nbsp;[贱笑]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[贱笑]&nbsp;[贱笑]&nbsp;[贱笑]&nbsp;","text":"$Pfizer(PFE)$[贱笑] [贱笑] [贱笑]","images":[{"img":"https://static.tigerbbs.com/bb173f780ecfd46e039f5f4768ce57fa","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/158440346","isVote":1,"tweetType":1,"viewCount":484,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":182511091,"gmtCreate":1623587998913,"gmtModify":1631892957637,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[冷漠]&nbsp;[冷漠]&nbsp;[冷漠]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[冷漠]&nbsp;[冷漠]&nbsp;[冷漠]&nbsp;","text":"$Apple(AAPL)$[冷漠] [冷漠] [冷漠]","images":[{"img":"https://static.tigerbbs.com/97ddbd61247e4b42c489947060b63ea7","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/182511091","isVote":1,"tweetType":1,"viewCount":1456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":873980988,"gmtCreate":1636841899814,"gmtModify":1636841900156,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"Good news.....","listText":"Good news.....","text":"Good news.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873980988","repostId":"1102251183","repostType":2,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其努力分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其努力分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847366823,"gmtCreate":1636495044938,"gmtModify":1636495045706,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Tesla Motors(TSLA)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/f2f53cce83b695dbeff08f53037b0bcd","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847366823","isVote":1,"tweetType":1,"viewCount":3274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":814110407,"gmtCreate":1630794545509,"gmtModify":1631883903339,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Pfizer(PFE)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/fb2cfe485bb4f70d9c8993272f9ba17c","width":"1080","height":"2259"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/814110407","isVote":1,"tweetType":1,"viewCount":427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":839374525,"gmtCreate":1629124491867,"gmtModify":1631885478937,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INTC\">$Intel(INTC)$</a>[捂脸]&nbsp;[喷血]&nbsp;","listText":"<a href=\"https://laohu8.com/S/INTC\">$Intel(INTC)$</a>[捂脸]&nbsp;[喷血]&nbsp;","text":"$Intel(INTC)$[捂脸] [喷血]","images":[{"img":"https://static.tigerbbs.com/dec3ac77b54e5aec96519c5885beef71","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/839374525","isVote":1,"tweetType":1,"viewCount":557,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":892921624,"gmtCreate":1628635584968,"gmtModify":1631885479078,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INTC\">$Intel(INTC)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/INTC\">$Intel(INTC)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Intel(INTC)$[看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/c9c8889ce290979a1db388b539ed51af","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/892921624","isVote":1,"tweetType":1,"viewCount":440,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":899130505,"gmtCreate":1628167455707,"gmtModify":1631885479146,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INTC\">$Intel(INTC)$</a>Why AMD up and Intel down??? Make sense???","listText":"<a href=\"https://laohu8.com/S/INTC\">$Intel(INTC)$</a>Why AMD up and Intel down??? Make sense???","text":"$Intel(INTC)$Why AMD up and Intel down??? Make sense???","images":[{"img":"https://static.tigerbbs.com/acd19466754ba66d69d665b44d5903a1","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/899130505","isVote":1,"tweetType":1,"viewCount":562,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":803172522,"gmtCreate":1627430007166,"gmtModify":1631892957645,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;fingers crossed....","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;fingers crossed....","text":"$Pfizer(PFE)$[看涨] [看涨] [看涨] fingers crossed....","images":[{"img":"https://static.tigerbbs.com/578913f5f0062c9807047ff0d2426575","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/803172522","isVote":1,"tweetType":1,"viewCount":395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":130675697,"gmtCreate":1621549660519,"gmtModify":1631892957670,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"[无语]&nbsp;","listText":"[无语]&nbsp;","text":"[无语]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/130675697","repostId":"1180231636","repostType":2,"isVote":1,"tweetType":1,"viewCount":527,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":105483298,"gmtCreate":1620316571314,"gmtModify":1631892957517,"author":{"id":"3582450584533032","authorId":"3582450584533032","name":"KLok","avatar":"https://static.tigerbbs.com/7d135114c7d99f91051322404730d3e0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582450584533032","authorIdStr":"3582450584533032"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[笑哭]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[笑哭]&nbsp;","text":"$Pfizer(PFE)$[笑哭]","images":[{"img":"https://static.tigerbbs.com/9308172464b4085ff0bb7bce0c733957","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/105483298","isVote":1,"tweetType":1,"viewCount":710,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"lives":[]}